The objective of the study was to investigate the clinicopathological features of primary colorectal signet-ring cell carcinoma. We retrospectively analyzed the clinical and survival data of 37 patients with primary colorectal signet-ring cell carcinoma. The mean survival time of patients in stage II, III, and IV were estimated using Student t test and the cumulative survival rates were estimated according to the method of KaplaneMeier. The significance of the differences in survival rates were calculated using the log rank test. The incidence of primary colorectal signet-ring cell carcinoma was 1.40%, the median age of 37 patients was 50 years, the male to female ratio was 1.47:1, and 21 patients (56.8%) received a radical resection. Most patients 33 (89.2%) had an advanced tumor stage at the time of diagnosis (17 patients 45.9% stage III and 16 patients 43.2% stage IV), 34 (94.5%) patients showed a tumor depth of >T3, lymph node involvement occurred in 26 patients (70.3%), patients had a high incidence of peritoneal metastasis (16 patients 43.2% at presentation, 30 patients 81.1% at presentation and recurrence) and a low incidence of liver metastases (1 patients 2.7% at presentation, 5 patients 13.5% at presentation and recurrence). The 5-year survival rate after the initial surgery was 10.8%, the mean survival time of 37 patients was 27.1 AE 3.3 months, the mean survival time of patients in stage II, III, and IV were 47.0 AE 12.8 months, 37.1 AE 3.9 months, and 10.5 AE 1.4 months, respectively (P < .000). Colorectal signet-ring cell carcinoma is a rare neoplasm with a predominance in men. Its characteristic features were the advanced stage at the time of diagnosis, a high incidence of peritoneal metastases, a low incidence of liver metastasis, and a poor prognosis.
Introduction
Colorectal signet-ring cell carcinoma is a subtype of colorectal mucinous adenocarcinoma characterized by cells with intracellular accumulation of mucin and the nuclei pushed to the periphery; tumor cells resemble signet rings (Figure 1 ). The tumor is composed of mass signet ring cells, no crypt structure, mucin mainly gathered in signet ring cells, but a few in the extracellular space. The most common location of primary signet-ring cell carcinomas arise in the stomach. 1 Colorectal signet-ring cell carcinoma is extremely rare among all patients with colorectal cancer; it was first described by Laufman and Saphir in 1951. 2 Its characteristics include more advanced stage and younger age at presentation, lower curative resection rate, higher local lymphatic spread and peritoneal metastasis, aggressive of biological behavior, and the prognosis is poorer than ordinary colorectal adenocarcinoma. [3] [4] [5] [6] [7] The aim of this study was to investigate the clinicopathological features and postoperative prognosis of colorectal signet-ring cell carcinoma.
Patients and Methods
From January 1990 to December 2010, 2643 patients with colorectal cancer had surgical resection and were diagnosed histologically at Affiliated Hospital of Guiayng Medical College. From these records of cases, 37 patients (1.4%) were histologically proven to have colorectal signet-ring cell carcinoma.
Pathologic examination and classification of colorectal signet-ring cell carcinoma were performed in accordance with the World Health Organization criteria, and the pathologic staging of disease was according to the American Joint Committee on Cancer (AJCC) staging manual, seventh edition. 8 
Follow-Up
The median follow-up period was 26 months (range, 3-80 months), 35 patients died and 2 patients were alive at the end of follow-up.
Statistics
The mean survival time of patients in stage II, III, and IV were estimated using Student t test and the cumulative survival rates estimated according to the method of KaplaneMeier. The significance of differences in survival rates were calculated using the log rank test; P values < .05 were considered to denote statistical significance.
Results

The Incidence of Colorectal Signet-Ring Cell Cancer
Of 2643 patients with primary colorectal carcinoma, 37 (1.40%) presented with histologically proven colorectal signet-ring cell carcinoma.
Age and Sex
Of the 37 patients, 22 were male and 15 were female; the male to female ratio was 1.47:1, with a predominance of men. The median age was 50 years (range, 22-82 years), Twenty-seven percent of the patients (n ¼ 10) were younger than 40 years at the time of diagnosis.
Site of Primary Tumor
Of the colorectal signet-ring cell carcinomas, 45.9% (n ¼ 17) were located in the rectum; the right hemicolon was the second most predominant site, representing 32.4% (n ¼ 12) (located in the cecum for 5 patients and in the ascending colon for 7 patients); 16.2% of the tumors (n ¼ 6) occurred in the transverse colon, 5.4% (n ¼ 2) in the sigmoid colon.
Family History of Cancer
Five patients (13.5%) had a family history of cancer, 2 patients had history of cancer, 1 patient had a history of cerebroma and another gastric cancer. The patient with gastric cancer was a woman, 72 years old, with the tumor located in the splenic flexure of the transverse colon and with peritoneal metastasis at presentation; she also had a family history of gastric (mother and 1 older sister) and hepatic cancer (another older sister).
Symptoms
The most frequent presenting symptoms were a change in bowel habits (23 patients; 62.2%), abdominal pain (20 patients; 54.1%), macroscopic rectal bleeding (9 patients; 24.3%), and abdominal mass (6 patients; 16.2%). Fourteen patients (37.8%) presented with acute obstruction.
Surgical Method
A curative resection (R0 resection) was performed in 21 patients (56.8%), noncurative surgery was performed in 16 patients (43.2%), including palliative resection performed in 10 patients (27.0%) and colectomy performed in 6 patients (16.2%). Of 37 cases, 27 patients (73.0%) accepted the elective surgery and 10 patients (27.0%) accepted the emergency surgery because of acute cancer-related bowel obstruction.
Tumor, Node, Metastases Stage at Diagnosis
According to the AJCC Tumor, Node, Metastases (TNM) system, the stage of 37 patients with colorectal signet-ring cell carcinoma are summarized in Table 1 . The patients with stage III and IV stage disease represented 89.2% of 37 cases at the time of diagnosis, the tumor depth of T3 þ T4 stage disease represented 94.6% of 37 cases. Twenty-six patients (70.3%) had local lymph node involvement.
Site of Metastatic Disease at Presentation and at Recurrence
The site of metastasis of colorectal signet-ring cell carcinoma at presentation and at recurrence are summarized in Table 2 . In colorectal signet-ring cell carcinoma, peritoneal metastasis was the most frequent (43.2% patients; n ¼ 16 at presentation, and 81.1% patients; n ¼ 30 at presentation and recurrence) and there was a low incidence of liver metastases (2.7% of patients [n ¼ 1] at presentation, 13.5% patients [n ¼ 5] at presentation and recurrence; Tables 3 and 4) .
Overall Survival
At the end of follow-up, 35 patients died, 34 patient died of cancer-related disease, and 1 patient died from noncancer-related disease and was excluded from survival analysis. Two patients are alive, 1 patient had a left breast metastasis 19 months after the first Features of Primary Colorectal Signet-Ring Cell Carcinoma surgery and the left breast metastasis was resected, another patient has survived disease-free for 80 months.
The 5-year survival rate was 10.8%. The mean survival time was 27.1 AE 3.3 months (range, 3-80 months). The mean disease-free survival time of patients who had a curative resection was 35.4 AE 4.4 (range, 3-80) months. The mean survival time after recurrence was 7.1 AE 1.7 months.
The mean survival time of patients in stage II, III, and IV were 47.0 AE 12.8 months (range, 11-67 months), 37.1 AE 3.9 months (range, 22-80 months), and 10.5 AE 1.4 months (range, 3-26 months), respectively (P < .000). Actuarial survivals for patients with stage II, III, and IV disease are shown in Figure 2 .
Discussion
Colorectal signet-ring cell carcinoma is very rare compared with other forms of colorectal adenocarcinoma; the reported incidence ranges from 0.1% to 5%t in Western countries, [3] [4] [5] [9] [10] [11] [12] [13] and the frequency was reported to be 1.19% to 4.6% in China. 14, 15 In our study, colorectal signet-ring cell carcinoma accounted for 1.40%, the frequency was consistent with the reported frequency in Western countries and China. However, in some countries, its frequency were reported to reach 18.5%, 16, 17 authors have suggested that signet-ring cell carcinoma of the colon and rectum occurs in younger patients than standard adenocarcinoma of the colon and rectum. 1, 9, 18, 21, 25 In agreement with these reported findings, our patients with colorectal signet-ring cell carcinoma were younger; the median age was 50 years, with 10 patients (27%) younger than 40 years at diagnosis. It seems likely that colorectal signet-ring cell carcinoma occurs easily in younger patients.
Many studies confirmed that patients with primary colorectal signet-ring cell carcinoma are in the advanced stage at the time of diagnosis; most patients developed lymph node metastasis or distant metastasis. [3] [4] [5] 9, [11] [12] [13] 25, 26 In the current study we found that 89.1%
patients presented with stage III and IV and 43.2% patients had distant metastases, 35 patients (94.6%) had more than fullthickness involvement of the bowel wall (T3 þ T4 stage) and 70.3% patients had local lymph nodes metastasis. The main reason was the delay in diagnosis because of the late manifestation of symptoms and the aggressive behavior of the tumor cells. Most colorectal signet-ring cell cancer presents as a diffusely infiltrating growth, 4,27-29 and a relatively long period of intramural growth without penetrating the mucosa. Patients had no serious symptoms such as rectal blood loss, or serious abdominal pain at the early stage of disease. In our study, the main symptom was a change in bowel habit; the symptoms might be so minor at the initial stage of disease that patients did not pay attention to the symptoms. This might result in an obvious delay in diagnosis. However, the disease developed quickly because of the aggressive behavior of signet-ring cell carcinoma. Some studies showed that colorectal signet-ring cell carcinoma has a significantly higher rate of venous and lymphatic vessel invasion than ordinary carcinoma; the growth pattern of colorectal signet-ring cell carcinoma is diffusely infiltrating growth, the tumor cells have a greater inclination to peritoneal seeding and infiltration into lymphatics and nodes, and an easier invasion into peri-intestinal tissue.
5,21
A high incidence of peritoneal metastasis and a relatively low incidence of liver, lung, and bone are regarded as one of characteristic features of colorectal signet-ring cell carcinoma; this pattern of metastasis is considered to be consistent with a high incidence of lymphatic invasion. [3] [4] [5] 12, 23 In our study, the predisposition to peritoneal metastasis of colorectal signet-ring cell carcinoma not only occurred at presentation but also at recurrence of disease. Thirty patients (81.1%) with colorectal signet ring cell carcinoma had peritoneal metastasis, however, liver metastasis only occurred in 5 patients (13.5%).
Clinically, colorectal signet-ring cell carcinoma presents with more advanced tumor stages at the time of first diagnosis, a high incidence of peritoneal metastasis and lymphatic invasion, a relatively low incidence of liver, lung, and bone metastasis than conventional colorectal adenocarcinoma. These features might be related to the molecular etiology of colorectal signet ring cell. On the molecular etiology of colorectal signet ring cell carcinoma, there has been examination of several molecular signatures including major oncogenic mutations in Kras (V-ki-ras2 Kirsten rat sarcoma viral oncogene homolog) and BRAF (B-Raf and v-raf murine sarcoma viral oncogene homolog B1), tumor suppressor genes, microsatellite instability (MSI), COX (cyclooxygenase)-2 protein, acid phosphatase, b-glucuronidase, and cellular adhesion molecules. 21, [30] [31] [32] [33] [34] A slightly lower prevalence of Kras mutation has been reported in colorectal signet ring cell carcinoma compared with conventional adenocarcinomas, 30 as well as a higher frequency of BRAF mutation in colorectal signet-ring cell carcinoma than conventional adenocarcinomas. 31 The tumor suppressor genes P53 and P16 were found with less expression in colorectal signet ring-cell carcinoma than in conventional adenocarcinomas, 32 this might indicate that a different percentage of P53 and P16 in colorectal signet-ring cell carcinoma might have altered biological behavior. MSI is caused by inactivation of a group of genes responsible for DNA mismatch repair. A study 31 reported that 30% of patients with colorectal signet ring cell carcinoma had MSI-high tumors; the results were 17% in patients with conventional adenocarcinomas, suggesting that colorectal signet ring cell carcinoma are more likely to be MSI-high tumors. COX-2 protein catalyzes the conversion of arachidonic acid to prostaglandins and is related to the genesis and maintenance of colorectal carcinoma. A study 33 showed reduced staining of COX-2 in colorectal signet-ring cell carcinoma than in conventional adenocarcinomas, indicative of DNA repair mechanisms. The fibrous tissue around the tumor was dissolved easily because of the high activity of acid phosphatase and b-glucuronidase in the signet-ring cell, 34 the mucin makes tissue encapsulation of the tumor more difficult, 21 because of the deficiency of cellular adhesion molecules of signet-ring cell carcinoma, the tumor cells fell off more easily from the primary tumor, the mucopolysaccharide prevents discrimination of host immunocytes for tumor cells and allows tumor cells easier invasion into peri-intestinal tissue and subsequent lymphatics. [35] [36] [37] The abnormal change of these molecular markers might be related to the poor prognosis of patients with colorectal signet-ring cell carcinoma. Prognosis of colorectal signet ring cell carcinoma is very poor; the 5-year overall survival rates were approximately 10% to 37%, [3] [4] [5] 7, 9, 13, [18] [19] [20] [21] 23, 26 and even 0%. 38 In our study, the 5-year survival rate was 10.8%, and the median survival time was 27.1 AE 3.3 months. However, some authors have considered that the survival of colorectal signet-ring cell carcinoma is similar to ordinary colorectal carcinoma; we believe that the poor prognosis of colorectal signet-ring cell carcinoma is related to a delayed diagnosis. There are few data concerning the overall survival of colorectal signet-ring cell carcinoma in each stage. In our study, the mean survival time of patients in stage II, III, and IV were 47.0 AE 12.8 months, 37.1 AE 3.9 months, and 10.5 AE 1.4 months; a significant difference was noted when compared stage for stage; the survival was influenced significantly by tumor stage. Another reason might be relationship with the type of metastasis and recurrence. In our study, 81.1% (30 of 37) patients with colorectal signet-ring cell cancer had peritoneal metastasis. The characteristic of peritoneal metastasis are: (1) peritoneal metastasis was covert, it is difficult to detect preoperatively. Symptoms of patients might be so slight at the onset that it could not be discovered in time. Imaging studies such as computed tomography and positron emission tomography have a low accuracy for detecting peritoneal cancer nodules 38 ; (2) there was not an effective treatment-a curative resection (R0) is very rare for patients with peritoneal metastasis, and many patients only received palliative procedures such as palliative segmental resection, bypass procedures, or colostomy or laparotomy-the prognosis is fairly poor 39, 40 ; and (3) adjuvant chemotherapy is the only treatment for these patients. However, long-term survival has not been achieved for many patients with peritoneal metastasis with intravenous chemotherapy because intravenous drugs have limited penetration through the peritoneum.
41,42
Conclusion
Colorectal signet-ring cell carcinoma of is a rare neoplasm; it is diagnosed at an advanced stage with a late TNM stage. A high incidence of peritoneal seeding at presentation and recurrence, low blood-borne metastasis, radical resection, younger age, advanced stage, and a poor prognosis were the characteristics of colorectal signet-ring cell carcinoma.
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